Indian Journal of Obstetrics and Gynecology Research
  • Year: 2016
  • Volume: 3
  • Issue: 4

Evaluation of benign ovarian tumours in a tertiary care centre

  • Author:
  • Vrunda Choudhary1, Sonali Somani2, Shashikant Somani3, Rajesh Kaul4
  • Total Page Count: 5
  • Page Number: 383 to 387

1Professor, Dept. of Obstetrics & Gynecology, Kamineni Institute of Medical Sciences, Telangana

2Assistant Professor, Dept. of Obstetrics & Gynecology, Kamineni Institute of Medical Sciences, Telangana

3Assistant Professor, Dept. of Physiology, Kamineni Institute of Medical Sciences, Telangana

4Professor & HOD, Dept. of Obstetrics & Gynecology, Kamineni Institute of Medical Sciences, Telangana

*Corresponding Author: Email: drsgsomani@gmail.com

Online published on 20 June, 2017.

Abstract

Present study was done to analyse the distribution of benign ovarian tumours in different age groups and to correlate their clinic-histopathological patterns.

In present retrospective study histopathologically proven 63 cases of benign ovarian tumours were analysed. The tumours were classified according to WHO classification after thorough examination of slides and their distribution in different age groups was noted.

Surface epithelial tumours were commonest (65.08%) followed by germ cell tumours (26.97%) and sex cord stromal tumours(7.95%). Maximum 34.93% ovarian tumours were found in 31–40 years age group. Most of the patients (33.34%) were asymptomatic and were diagnosed incidentally. Commonest tumour was serous cystadenoma (38.09%) followed by mucinous cystadenoma (25.389%) and benign cystic teratoma (17.45%).

Ovarian tumours are common in forth decade. Most common histopathological presentation was surface epithelial tumours with preponderance of serous cystadenomas. Most of them remain asymptomatic, therefore clinicohistopathological diagnosis still remains gold standard which is helpful for early detection and proper management.

Keywords

Benign ovarian tumours, Histopathology, Surface epithelial tumours, Germ cell tumours, Sex cord stromal tumours